Venkatraman Balakrishnan

Venkatraman Balakrishnan

Active Director Designated Partner DIN 02825465
DIN 02825465 First appointment Nov 2009 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 13 active board seats
Past companies 9 historical roles
Total affiliations 22 Since Nov 2009
Shareholding value Locked Premium profile
Directorship timeline
First appointment 09 Nov 2009
Active appointments 15
Total timeline records 22

Appointment history

Since 2009
Dr. Agarwal's Eye Hospital Limited Director · 2022 - 2026
Current
Balki Advisory Services Llp Designated Partner · 2020 - 2026
Current
Dr. Agarwal's Health Care Limited Director · 2019 - 2026
Current
Singular Investments Consultancy Llp Designated Partner · 2019 - 2026
Current
Current
Ideaspring Advisors Llp Partner · 2016 - 2026
Current
Startupxseed Ventures Llp Partner · 2015 - 2026
Current
Singular Capital India Advisors Llp Partner · 2015 - 2026
Current
Exfinity Venture Partners Llp Designated Partner · 2015 - 2026
Current
Kaar Technologies India Private Limited Director · 2015 - 2026
Current
Current
Clonect Solutions Private Limited Director · 2014 - 2026
Current
Avekshaa Technologies Private Limited Director · 2014 - 2026
Current
Micrograam Marketplace Private Limited Director · 2013 - 2026
Current
7Rays Ventures Llp Designated Partner · 2019 - 2019
Previous
Growx Techdeals Llp Partner · 2018 - 2025
Previous
Bluereservoir Business Services Llp Designated Partner · 2015 - 2023
Previous
Infosys Bpm Limited Director · 2011 - 2013
Previous
Infosys Limited Whole-Time Director · 2011 - 2013
Previous
Previous
Tejas Networks Limited Director · 2009 - 2022
Previous

Interactive timeline

Hover bars for tenure details
Loading chart...
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available